Spineway SA (ALSPW.PA)

EUR 0.08

(-1.89%)

EBITDA Summary of Spineway SA

  • Spineway SA's latest annual EBITDA in 2023 was -4.79 Million EUR , down -39.86% from previous year.
  • Spineway SA's latest quarterly EBITDA in 2024 Q2 was -854 Thousand EUR , down 0.0% from previous quarter.
  • Spineway SA reported an annual EBITDA of -2.76 Million EUR in 2022, down -315.58% from previous year.
  • Spineway SA reported an annual EBITDA of -719 Thousand EUR in 2021, up 13.37% from previous year.
  • Spineway SA reported a quarterly EBITDA of -2.29 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Spineway SA reported a quarterly EBITDA of -488 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Spineway SA (2023 - 2011)

Historical Annual EBITDA of Spineway SA (2023 - 2011)

Year EBITDA EBITDA Growth
2023 -4.79 Million EUR -39.86%
2022 -2.76 Million EUR -315.58%
2021 -719 Thousand EUR 13.37%
2020 -1.31 Million EUR 46.35%
2019 -1.54 Million EUR 51.17%
2018 -3.16 Million EUR -3005.88%
2017 -102 Thousand EUR 93.12%
2016 -1.48 Million EUR -44.05%
2015 -1.32 Million EUR 14.25%
2014 -1.26 Million EUR -788.37%
2013 200.05 Thousand EUR -62.53%
2012 533.68 Thousand EUR 22.59%
2011 379.66 Thousand EUR 0.0%

Peer EBITDA Comparison of Spineway SA

Name EBITDA EBITDA Difference
Crossject Société Anonyme -7.29 Million EUR 34.334%
Safe Orthopaedics SA -5.62 Million EUR 14.812%
Amplitude Surgical SA 24.72 Million EUR 119.375%
Sartorius Stedim Biotech S.A. 777.2 Million EUR 100.616%
EssilorLuxottica Société anonyme 6.18 Billion EUR 100.078%
bonyf N.V. -39.89 Thousand EUR -11909.298%